Impact of self-efficacy education on physical and psychosocial functioning in newly-diagnosed Parkinson patients
Objective: To evaluate whether this program improves physical and psychosocial functioning in newly-diagnosed persons with Parkinson's disease (PWP) over the 12-month period of the intervention…The effect of a structured medication review on quality of life in patients with Parkinson’s disease. An interim analysis
Objective: To investigate whether a structured medication review executed by a community pharmacist improves medication adherence and influences quality of life in patients with Parkinson's…The association between objectively measured physical activity and health-related-quality of life in people with Parkinson’s disease
Objective: To evaluate the association between a large number of objectively measured parameters of physical activity in the domestic environment using wearable sensors and Health-Related-Quality…My PD Journey: Experiences reported by people with Parkinson’s disease in several European countries – A quantitative and qualitative study
Objective: To document experience of service provision by people with Parkinson's disease (PD) care in Europe. Background: Developed by the EPDA, My PD Journey is…Broadening the evaluative scope of quality of life in Parkinson’s: Testing the construct validity of the ICECAP-O instrument
Objective: To test the construct validity of ICECAP-O in Parkinson's and explore its relationship with the EQ-5D and the PDQ-39. Background: Parkinson's significantly affects patients'…Evaluation of stigmatization and quality of life before and after botulinum toxin treatment in hemifacial spasm
Objective: Hemifacial spasm (HFS) is a chronic disease that is characterized by involuntary tonic and clonic contractions of the muscles innervated by the ipsilateral facial…Twelve-week sensor assessment in Parkinson’s disease: Impact on quality of life
Objective: To evaluate the effects of using wearables over a long time period on Health-Related Quality of Life (HRQoL) in Parkinson's disease (PD) patients. Background:…How long is the wait to see a Parkinson’s disease specialist in the United States?
Objective: To investigate the wait time to see a PD specialist in the US. Background: PD patients who see a specialist have better outcomes and…Measuring interdependence of the health status of people with Parkinson’s disease and their spouses
Objective: To demonstrate an innovative visualization method for measuring the interdependence of the health status of people with Parkinson's disease (PD) and their spouses over…The social value of improvement in activities of daily living from levodopa-carbidopa intestinal gel use among the advanced Parkinson’s disease population
Objective: Quantify the value of improvement in functional status (FS) measured as activities of daily living (ADL) limitations, from levodopa-carbidopa intestinal gel (LCIG) use among…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.